VANCOMYCINE SANDOZ 125 mg, powder for concentrate for infusion bottle
Active ingredients: Vancomycin hydrochloride, Vancomycin
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusionbottleintrapéritonéale;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VANCOMYCINE SANDOZ 125 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intrapéritonéale;intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60900335CIP75661315CIP133400956613151Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE VANCOMYCINEpoudre | 125 mg · un flacon | SA |
| VANCOMYCINE BASEpoudre | 125 000 UI · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.